Template:PDB Gallery/3630

• 
  1ai0: R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES
• 
  1aiy: R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES
• 
  1aph: CONFORMATIONAL CHANGES IN CUBIC INSULIN CRYSTALS IN THE PH RANGE 7-11
• 
  1b17: PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 5.00 COORDINATES)
• 
  1b18: PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 5.53 COORDINATES)
• 
  1b19: PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 5.80 COORDINATES)
• 
  1b2a: PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 6.00 COORDINATES)
• 
  1b2b: PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 6.16 COORDINATES)
• 
  1b2c: PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 6.26 COORDINATES)
• 
  1b2d: PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 6.35 COORDINATES)
• 
  1b2e: PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 6.50 COORDINATES)
• 
  1b2f: PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 6.98 COORDINATES)
• 
  1b2g: PH AFFECTS GLU B13 SWITCHING AND SULFATE BINDING IN CUBIC INSULIN CRYSTALS (PH 9.00 COORDINATES)
• 
  1b9e: HUMAN INSULIN MUTANT SERB9GLU
• 
  1ben: INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE
• 
  1bph: CONFORMATIONAL CHANGES IN CUBIC INSULIN CRYSTALS IN THE PH RANGE 7-11
• 
  1cph: CONFORMATIONAL CHANGES IN CUBIC INSULIN CRYSTALS IN THE PH RANGE 7-11
• 
  1dph: CONFORMATIONAL CHANGES IN CUBIC INSULIN CRYSTALS IN THE PH RANGE 7-11
• 
  1ev3: Structure of the rhombohedral form of the M-cresol/insulin R6 hexamer
• 
  1ev6: Structure of the monoclinic form of the M-cresol/insulin R6 hexamer
• 
  1evr: The structure of the resorcinol/insulin R6 hexamer
• 
  1fu2: FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA
• 
  1fub: FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA
• 
  1g7a: 1.2 A structure of T3R3 human insulin at 100 K
• 
  1g7b: 1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K
• 
  1guj: INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING INSULIN FIBRE FORMATION.
• 
  1hiq: PARADOXICAL STRUCTURE AND FUNCTION IN A MUTANT HUMAN INSULIN ASSOCIATED WITH DIABETES MELLITUS
• 
  1hit: RECEPTOR BINDING REDEFINED BY A STRUCTURAL SWITCH IN A MUTANT HUMAN INSULIN
• 
  1hls: NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16)
• 
  1htv: CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN
• 
  1iza: ROLE OF B13 GLU IN INSULIN ASSEMBLY: THE HEXAMER STRUCTURE OF RECOMBINANT MUTANT (B13 GLU-> GLN) INSULIN
• 
  1izb: ROLE OF B13 GLU IN INSULIN ASSEMBLY: THE HEXAMER STRUCTURE OF RECOMBINANT MUTANT (B13 GLU-> GLN) INSULIN
• 
  1j73: Crystal structure of an unstable insulin analog with native activity.
• 
  1jca: Non-standard Design of Unstable Insulin Analogues with Enhanced Activity
• 
  1jco: Solution structure of the monomeric [Thr(B27)->Pro,Pro(B28)->Thr] insulin mutant (PT insulin)
• 
  1lph: LYS(B28)PRO(B29)-HUMAN INSULIN
• 
  1m5a: Crystal Structure of 2-Co(2+)-Insulin at 1.2A Resolution
• 
  1mhi: THREE-DIMENSIONAL SOLUTION STRUCTURE OF AN INSULIN DIMER. A STUDY OF THE B9(ASP) MUTANT OF HUMAN INSULIN USING NUCLEAR MAGNETIC RESONANCE DISTANCE GEOMETRY AND RESTRAINED MOLECULAR DYNAMICS
• 
  1mhj: SOLUTION STRUCTURE OF THE SUPERACTIVE MONOMERIC DES-[PHE(B25)] HUMAN INSULIN MUTANT. ELUCIDATION OF THE STRUCTURAL BASIS FOR THE MONOMERIZATION OF THE DES-[PHE(B25)] INSULIN AND THE DIMERIZATION OF NATIVE INSULIN
• 
  1mpj: X-RAY CRYSTALLOGRAPHIC STUDIES ON HEXAMERIC INSULINS IN THE PRESENCE OF HELIX-STABILIZING AGENTS, THIOCYANATE, METHYLPARABEN AND PHENOL
• 
  1mso: T6 Human Insulin at 1.0 A Resolution
• 
  1os3: Dehydrated T6 human insulin at 100 K
• 
  1os4: Dehydrated T6 human insulin at 295 K
• 
  1q4v: CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR
• 
  1qiy: HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL
• 
  1qiz: HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL
• 
  1qj0: HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR
• 
  1rwe: Enhancing the activity of insulin at receptor edge: crystal structure and photo-cross-linking of A8 analogues
• 
  1sf1: NMR STRUCTURE OF HUMAN INSULIN under Amyloidogenic Condition, 15 STRUCTURES
• 
  1t0c: Solution Structure of Human Proinsulin C-Peptide
• 
  1trz: CRYSTALLOGRAPHIC EVIDENCE FOR DUAL COORDINATION AROUND ZINC IN THE T3R3 HUMAN INSULIN HEXAMER
• 
  1tyl: THE STRUCTURE OF A COMPLEX OF HEXAMERIC INSULIN AND 4'-HYDROXYACETANILIDE
• 
  1tym: THE STRUCTURE OF A COMPLEX OF HEXAMERIC INSULIN AND 4'-HYDROXYACETANILIDE
• 
  1uz9: CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N-LITHOCHOLYL INSULIN: A NEW GENERATION OF PROLONGED-ACTING INSULINS.
• 
  1w8p: STRUCTURAL PROPERTIES OF THE B25TYR-NME-B26PHE INSULIN MUTANT.
• 
  1wav: CRYSTAL STRUCTURE OF FORM B MONOCLINIC CRYSTAL OF INSULIN
• 
  1xda: STRUCTURE OF INSULIN
• 
  1xgl: HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES
• 
  1xw7: Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies of A-Chain Variant Insulin Wakayama
• 
  1zeg: STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL
• 
  1zeh: STRUCTURE OF INSULIN
• 
  1zni: INSULIN
• 
  1znj: INSULIN, MONOCLINIC CRYSTAL FORM
• 
  2a3g: The structure of T6 bovine insulin
• 
  2aiy: R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES
• 
  2bn1: INSULIN AFTER A HIGH DOSE X-RAY BURN
• 
  2bn3: INSULIN BEFORE A HIGH DOSE X-RAY BURN
• 
  2c8q: INSULINE(1SEC) AND UV LASER EXCITED FLUORESCENCE
• 
  2c8r: INSULINE(60SEC) AND UV LASER EXCITED FLUORESCENCE
• 
  2g4m: Insulin collected at 2.0 A wavelength
• 
  2g54: Crystal structure of Zn-bound human insulin-degrading enzyme in complex with insulin B chain
• 
  2g56: crystal structure of human insulin-degrading enzyme in complex with insulin B chain
• 
  2hiu: NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES
• 
  2ins: THE STRUCTURE OF DES-PHE B1 BOVINE INSULIN
• 
  2omg: Structure of human insulin cocrystallized with protamine and urea
• 
  2omh: Structure of human insulin cocrystallized with ARG-12 peptide in presence of urea
• 
  2omi: Structure of human insulin cocrystallized with protamine
• 
  2tci: X-RAY CRYSTALLOGRAPHIC STUDIES ON HEXAMERIC INSULINS IN THE PRESENCE OF HELIX-STABILIZING AGENTS, THIOCYANATE, METHYLPARABEN AND PHENOL
• 
  3aiy: R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE
• 
  3ins: STRUCTURE OF INSULIN. RESULTS OF JOINT NEUTRON AND X-RAY REFINEMENT
• 
  3mth: X-RAY CRYSTALLOGRAPHIC STUDIES ON HEXAMERIC INSULINS IN THE PRESENCE OF HELIX-STABILIZING AGENTS, THIOCYANATE, METHYLPARABEN AND PHENOL
• 
  4aiy: R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'GREEN' SUBSTRATE, AVERAGE STRUCTURE
• 
  4ins: THE STRUCTURE OF 2ZN PIG INSULIN CRYSTALS AT 1.5 ANGSTROMS RESOLUTION
• 
  5aiy: R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'RED' SUBSTRATE, AVERAGE STRUCTURE
• 
  6ins: X-RAY ANALYSIS OF THE SINGLE CHAIN /B29-A1$ PEPTIDE-LINKED INSULIN MOLECULE. A COMPLETELY INACTIVE ANALOGUE
• 
  7ins: STRUCTURE OF PORCINE INSULIN COCRYSTALLIZED WITH CLUPEINE Z
• 
  9ins: MONOVALENT CATION BINDING IN CUBIC INSULIN CRYSTALS